H.C. Wainwright raised the firm’s price target on Alkermes to $34 from $32 and keeps a Neutral rating on the shares. The company’s proprietary commercial portfolio showed growth in Q1, the analyst tells investors in a research note. The firm is now incorporating ALKS 2680 into its valuation model.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ALKS: